Top Growth Trends in the Artificial Pancreas Device System Market: Key Insights and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the artificial pancreas device system market grown over the years?
The artificial pancreas device system market has experienced strong growth in recent years. It is expected to rise from $1.81 billion in 2024 to $2.07 billion in 2025, with a compound annual growth rate (CAGR) of 14.1%. Contributing factors include rising investment inflows, growing government initiatives in clinical research, higher demand for automated glycemic control systems, intensive R&D by industry players, and an expanding elderly population.
What Is the forecasted market size and growth rate for the artificial pancreas device system market?
The artificial pancreas device system market is anticipated to grow rapidly, reaching $3.48 billion by 2029, at a CAGR of 13.9%. Factors contributing to this growth include the rising incidence of diabetes and pancreatic cancer, the increased demand for minimally invasive drug delivery systems, and ongoing innovations in diabetes management technology. Trends include technological breakthroughs, growing research efforts, increased product approvals, and the rise in teleconsultancy for follow-up care.
Get your artificial pancreas device system market report here!
What are the major factors driving growth in the artificial pancreas device system market?
The artificial pancreas device system market is expected to grow due to the increasing prevalence of pancreatic cancer. Pancreatic cancer, influenced by lifestyle, genetic, and environmental factors, is becoming more common. Artificial pancreas systems help diabetes patients manage blood sugar levels by automatically monitoring glucose and delivering insulin. Cancer Australia reported an increase in pancreatic cancer cases in 2023, with 4,506 new diagnoses, up from 3,751 over the previous five years. This rise in cases will further propel the demand for artificial pancreas systems.
What key areas define the segmentation of the global artificial pancreas device system Market?
The artificial pancreas device system market covered in this report is segmented –
1) By Device Type: Threshold Suspend Device Systems, Control-To-Range Systems, Control-To-Target Systems
2) By Treatment Type: Bi-Hormonal, Insulin Only, Hybrid
3) By End-User: Hospitals, Medical Centers, Other End-Users
Subsegments:
1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend, Continuous Glucose Monitoring (CGM) Integrated Systems
2) By Control-To-Range Systems: Hybrid Closed-Loop Systems, Insulin Delivery Systems with Range Control, Real-Time Glucose Adjustment Systems
3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems, Insulin Pumps with Targeted Glucose Control, Automated Glucose Regulation Systems
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp
What are the top market players propelling the growth of the artificial pancreas device system industry?
Major companies operating in the artificial pancreas device system market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Juvenile Diabetes Research Foundation (JDRF), Beta Bionics Inc., Glooko Inc., Bigfoot Biomedical Inc., CeQur SA, Medtrum Technologies Inc., Diabeloop SA, Beta-O2 Technologies Ltd, Pancreum Inc., TypeZero Technologies LLC, Inreda Diabetic B.V., Defymed SAS, Admetsys Corporation, DreaMed Diabetes Ltd
What are the key trends shaping the future of the artificial pancreas device system market?
In the artificial pancreas device system market, companies are developing automated insulin delivery systems to improve diabetes management by continuously monitoring blood glucose levels and automatically administering insulin. These systems aim to reduce the burden of manual blood sugar monitoring and insulin injection. For example, in May 2023, Beta Bionics, a US-based medical device company, received FDA 510(k) clearance for its iLet Insulin-Only Bionic Pancreas System. This device autonomously adjusts insulin doses based on glucose levels, providing more precise and convenient diabetes management for users.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18229
What regions are dominating the artificial pancreas device system market growth?
North America was the largest region in the artificial pancreas device system market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Automotive Artificial Intelligence Global Market Report 2024
Artificial Intelligence in Military Global Market Report 2024
Artificial Intelligence in Healthcare Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
